Description

Amigren (Sumatriptan) Capsules 50 mg. N3

Ingredients

Active ingredient: Sumatriptan succinate 50 mg.

Mechanism of Action

Sumatriptan, a selective serotonin receptor agonist, constricts blood vessels in the brain, reducing inflammation and pain associated with migraines.

Pharmacological Properties

Sumatriptan succinate, the active component of Amigren, exhibits its therapeutic effects by targeting serotonin receptors in the brain, leading to vasoconstriction and alleviation of migraine symptoms.

Indications for Use

Indications: Amigren capsules are indicated for the acute treatment of migraine attacks with or without aura.

Contraindications

Contraindications: Amigren should not be used in individuals with uncontrolled hypertension, ischemic heart disease, or a history of stroke.

Side Effects

Common side effects of Amigren may include dizziness, drowsiness, chest discomfort, and tingling sensations. If any adverse reactions occur, discontinue use and seek medical advice.

Usage Instructions

Dosage: The recommended dose is one 50 mg capsule at the onset of migraine symptoms. Do not exceed 200 mg in a 24-hour period. Swallow the capsule whole with water; do not crush or chew it.

Benefits Compared to Analogues

Amigren offers a distinct advantage over other migraine medications due to its rapid onset of action and proven efficacy in relieving various migraine symptoms, providing patients with quick and reliable relief.

Suitable Patient Groups

Amigren is suitable for adult patients experiencing acute migraine attacks. It is not recommended for use in children, pregnant women, or individuals with certain cardiovascular conditions without medical supervision.

Storage and Shelf Life

Store Amigren capsules in a cool, dry place away from direct sunlight. Check the expiry date on the packaging and do not use the product after the stated shelf life has passed.

Packaging Description

Amigren capsules are typically packaged in blister packs containing a specified number of capsules. The packaging is designed to protect the medication from environmental factors and ensure dosage accuracy.

Clinical Evidence and Proven Effectiveness

Sumatriptan, the active ingredient in Amigren, has been extensively studied in clinical trials, demonstrating its efficacy in relieving migraine symptoms such as headache, nausea, and sensitivity to light and sound. Research supports the rapid relief and improved quality of life provided by sumatriptan in migraine management.